This conference will explore the macro trends affecting RWE across the lifecycle of medicines from development to post approval market use. Advanced analytics and integrated solutions are taking RWE use to the next level, inviting conversations about the quality of different types of RWE sources and how to best approach a unified framework for clinical data collection. We will discuss how RWE can support regulatory, physician and health care provider decision-making as well as optimization of clinical trial design. Join the discussions about patient involvement in RWE design and discover how various stakeholders are leveraging RWE to advance healthcare knowledge and decision-making processes as they are increasingly delegated to AI and related technologies.